Get App
Download App Scanner
Scan to Download
Advertisement

Honasa Consumer Shares Can Zoom 42% Says ICICI Securities Post Strong Q2 Numbers — Check Target Price

Honasa Consumer Shares Can Zoom 42% Says ICICI Securities Post Strong Q2 Numbers — Check Target Price
Expanding offline footprint, improving mix and disciplined cost control supported Honasa Consumer's steady margin progression in Q2.   (Photo: company website)
STOCKS IN THIS STORY
Honasa Consumer Ltd
--
  • Honasa Q2 FY26 revenue rose 17% YoY with volume growth of 16.7% reflecting steady performance
  • Revenue on like-for-like basis grew 22.5% YoY after adjusting for Flipkart settlement impact
  • Mamaearth and younger brands like The Derma Co. showed strong portfolio resilience and growth
Did our AI summary help?
Let us know.

Honasa's Q2 FY26 revenue / gross profit grew 17% / 19% YoY with underlying volume growth at +16.7%, reflecting steady volume-led performance. On a like-for-like basis (adjusted for the Flipkart settlement change of ~Rs 280 million), revenue grew 22.5% YoY, with no impact on absolute profitability as brand contribution remained unchanged.

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities Report

Honasa Consumer Ltd.'s Q2 FY26 performance reaffirms its focus on building category depth, scaling younger brands, and strengthening distribution reach.

Mamaearth is back to growth (like-for-like: double digit) and sustained traction across younger brands such as The Derma Co. underscoring portfolio resilience, while continued innovation and selective entry into premium segments strengthened category relevance.

Expanding offline footprint, improving mix and disciplined cost control supported steady margin progression in Q2. With younger brands now contributing >50% of revenue, new initiatives such as Luminéve in premium skincare and Fang in oral care broaden Honasa's play in emerging adjacencies.

The business enters H2 FY26 on a steady footing, with margin tailwinds and broad-based brand momentum likely to drive healthy performance ahead. Buy.

Key risks:

  • Heightened competition,

  • execution miss,

  • low success in scale-up of new brands and

  • continued slowdown in Mamaearth.

Click on the attachment to read the full report:

ICICI Securities -Honasa COonsumer Q2FY26_Results_Nov25.pdf
VIEW DOCUMENT

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search